(1)
Comparison of the Efficacy of Solifenacin Succinate and Tolterodine for the Treatment of Overactive Bladder Syndrome. Northern Int. Med. Coll. J. 2017, 8 (2), 231-234. https://doi.org/10.3329/nimcj.v8i2.32557.